Opus Genetics (IRD) EBT Margin (2010 - 2026)
Opus Genetics (IRD) reported EBT Margin of -1072.58% for Q2 2026, down 815.12 percentage points from -257.46% a year earlier but up 1965.66 percentage points from the prior quarter.
Powered by 
Analysis
Opus Genetics (IRD) EBT Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Opus Genetics' EBT Margin came in at -1091.82%, down 713.93 percentage points year-over-year; for FY2025, it was -349.33%, up 174.07 percentage points from FY2024.
- EBT Margin has a four-year change of +9275.97 percentage points (FY2021 to FY2025).
- By year, EBT Margin came in at -523.40% in FY2024 (-471.04 pp), -52.36% in FY2023 (-98.04 pp), 45.68% in FY2022 (+9670.98 pp) and -9625.30% in FY2021.
- Five-year quarterly EBT Margin spans a low of -3038.25% in Q1 2026 and a high of 85.96% in Q4 2022.
- Year over year, EBT Margin gained in three of the last eight quarters, with an average year-over-year change of -469.33 percentage points.
- The high point for year-over-year EBT Margin in five years was Q2 2025 (a gain of 440.83 percentage points); the low point was Q1 2026 (a drop of 2850.74 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -3038.25% (Q1 2026), -427.50% (Q4 2025) and -566.87% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Opus Genetics | 417.37 Mn | 192.65 Mn | - | -1,072.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,072.58% |
| Mar 31, 2026 | -3,038.25% |
| Dec 31, 2025 | -427.50% |
| Sep 30, 2025 | -566.87% |
| Jun 30, 2025 | -257.46% |
| Mar 31, 2025 | -187.51% |
| Dec 31, 2024 | -816.71% |
| Sep 30, 2024 | -194.62% |
| Jun 30, 2024 | -698.29% |
| Mar 31, 2024 | -415.31% |
| Dec 31, 2023 | -283.68% |
| Sep 30, 2023 | 46.71% |
| Jun 30, 2023 | -135.03% |
| Mar 31, 2023 | -331.10% |
| Dec 31, 2022 | 85.96% |
| Sep 30, 2021 | -865.03% |
| Jun 30, 2021 | -7,136.00% |
| Mar 31, 2020 | -268.52% |
| Jun 30, 2010 | -16,867.98% |
API Access
Opus Genetics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=IRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "IRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=IRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();